For many people living with major depression, first-line treatments such as antidepressants and therapy can make a meaningful difference. But not everyone gets the relief they need from standard care. Treatment-resistant depression can leave patients feeling exhausted, discouraged, and unsure where to turn next.
At Revitalizing Therapies in Kissimmee, we offer ketamine therapy as part of a thoughtful, individualized care model for appropriate candidates. Ketamine is not FDA-approved for depression; its psychiatric use is considered off-label. For some patients, however, it may be an option worth discussing when conventional treatments have not been enough.
The Weight of Treatment-Resistant Depression
Treatment-resistant depression is commonly described as depression that has not responded adequately to at least two antidepressant trials taken at appropriate doses and durations. It is not a rare or minor concern. The National Institute of Mental Health has estimated that treatment-resistant depression affects nearly 3 million people in the United States.
For many patients, the experience is deeply frustrating. They may have tried different medications, adjusted dosages, added therapy, changed routines, and followed every recommendation they were given—yet still feel weighed down by low mood, fatigue, hopelessness, sleep disruption, or loss of interest in life.
At Revitalizing Therapies, rethinking mental health means recognizing that a limited response to standard treatments is not a personal failure. It is clinical information. And it may mean a different approach is worth exploring.
Patients who want to better understand this experience can also read our related blog on what happens when standard antidepressants fail.
How Ketamine Is Different
Many traditional antidepressants work primarily through serotonin, norepinephrine, or dopamine pathways. Ketamine works differently. It interacts with the glutamate system, including NMDA receptor activity, which is one reason researchers continue to study its potential role in treatment-resistant depression.
Research suggests ketamine may have rapid antidepressant effects in some studied patients, sometimes within hours or days. That timing is one reason ketamine has received significant clinical and scientific attention. Still, response varies by individual, and ketamine should not be presented as a guaranteed or permanent solution.
At Revitalizing Therapies, we discuss ketamine’s off-label status, potential benefits, risks, limitations, and alternatives during consultation. Our goal is to help patients make informed decisions, not to pressure them into care.
For a deeper look at the science, our blog on why ketamine may work differently for depression offers additional context.
A Kissimmee Practice Built Around Evaluation and Support
Revitalizing Therapies serves patients in Kissimmee, Orlando, St. Cloud, Poinciana, Celebration, and surrounding Central Florida communities. Our Kissimmee office is located at 100 E Dakin Ave, Kissimmee, FL 34741.
Before treatment begins, our clinical team reviews each patient’s medical history, psychiatric history, prior treatment response, current medications, and goals. This evaluation helps determine whether ketamine therapy may be appropriate and whether other services should be part of the care plan.
Our approach is personal, not one-size-fits-all. Some patients may be exploring ketamine after years of medication trials. Others may be comparing ketamine with options such as SPRAVATO®, TMS therapy, psychiatry, counseling, or integrative medicine. We help patients understand which path may best fit their clinical picture.
Patients who feel nervous about the treatment experience can read our guide on preparing for your first ketamine session.
How Ketamine Fits With Other Depression Treatment Options
Ketamine therapy is one option among several that may be considered for treatment-resistant depression. Revitalizing Therapies also offers depression treatment options that may include psychiatry, counseling, medication management, integrative medicine, SPRAVATO®, and TMS therapy when clinically appropriate.
It is important to keep these treatments distinct:
Ketamine therapy is used off-label for psychiatric conditions, including depression.
SPRAVATO® is an FDA-approved esketamine nasal spray indicated for adults with treatment-resistant depression, as monotherapy or in conjunction with an oral antidepressant, and for depressive symptoms in adults with major depressive disorder with acute suicidal ideation or behavior, in conjunction with an oral antidepressant. SPRAVATO® is administered under REMS requirements in a certified healthcare setting.
TMS therapy is an FDA-cleared, noninvasive treatment that uses magnetic pulses to stimulate targeted areas of the brain involved in mood regulation.
For patients comparing options, our guide to the differences between SPRAVATO® and ketamine therapy may be a helpful next read.
Cost, Insurance, and Getting Started
Ketamine infusions for psychiatric conditions are generally not covered by insurance because they are used off-label. Revitalizing Therapies is transparent about costs from the beginning and can discuss available financing options before a patient commits to care.
Insurance coverage may differ for services such as SPRAVATO®, psychiatry, counseling, or TMS therapy, depending on the service and plan. Our team can help patients understand what verification steps may be appropriate.
The first step is a free consultation. During that conversation, our team can answer questions, review your history, and help determine whether ketamine therapy, SPRAVATO®, TMS therapy, or another option may be a better fit.
Frequently Asked Questions
What is treatment-resistant depression, and do I qualify for ketamine therapy?
Treatment-resistant depression is generally understood as depression that has not responded adequately to at least two antidepressant trials taken at appropriate doses and durations. During your free consultation at Revitalizing Therapies, our clinical team will review your history and help determine whether ketamine therapy may be appropriate.
How quickly does ketamine therapy work for depression?
Some patients may notice changes in mood within hours to days after treatment, but responses vary. Ketamine is not a guaranteed treatment, and a personalized plan is built around each patient’s history, goals, and response.
Is ketamine therapy safe?
Ketamine has a long history of use in medical settings. For psychiatric care, careful screening, dosing, monitoring, and follow-up are important. At Revitalizing Therapies, each patient is evaluated before treatment, and sessions take place in a monitored clinical environment.
How many ketamine infusions will I need?
Many patients begin with an initial series of treatments, but the number and schedule can vary based on clinical history, goals, and response. Your provider will discuss a personalized plan during consultation.
Will my insurance cover ketamine therapy for depression?
Ketamine infusions for psychiatric conditions are generally not covered by insurance because this use is off-label. Revitalizing Therapies can discuss pricing and available financing options before treatment begins. To get started, contact our Kissimmee office at 321-483-2917.
Key Takeaways
- Treatment-resistant depression can occur when standard antidepressant treatment has not provided adequate relief.
- Ketamine therapy for depression is an off-label use and should be considered only after careful clinical evaluation.
- Ketamine works differently from many traditional antidepressants by interacting with the glutamate system.
- Revitalizing Therapies also offers related options such as SPRAVATO®, TMS therapy, psychiatry, counseling, medication management, and integrative medicine when appropriate.
- Results vary by individual, and every treatment plan should be personalized.
A Different Path Forward in Kissimmee
Living with treatment-resistant depression can feel isolating, especially when you have already tried multiple options without enough relief. You deserve care that takes your history seriously and helps you explore what may still be possible.
At Revitalizing Therapies, our Kissimmee team supports patients with thoughtful evaluation, clinical care, and a warm, whole-person approach. Visit us at 100 E Dakin Ave, Kissimmee, FL 34741 or contact us to schedule a free consultation.
References
https://www.nimh.nih.gov/news/science-updates/2023/cracking-the-ketamine-code — National Institute of Mental Health: Cracking the Ketamine Code
https://www.nimh.nih.gov/research/research-funded-by-nimh/research-initiatives/rapidly-acting-treatments-for-treatment-resistant-depression-rapid — National Institute of Mental Health: Rapidly-Acting Treatments for Treatment-Resistant Depression
https://pmc.ncbi.nlm.nih.gov/articles/PMC9010394/ — Ketamine Treatment for Depression: A Review
https://www.spravatorems.com/ — SPRAVATO® REMS Program
About Michael McGowan
Michael McGowan, APRN, CRNA, serves as Clinical Director at Revitalizing Therapies. He brings extensive anesthesia experience across surgical, trauma stabilization, acute pain, and chronic pain settings. Ketamine infusions have played a significant role in his anesthetic practice in both hospital and clinical environments, and he brings years of experience administering ketamine safely and effectively. Michael is known for his patient-centered approach, clinical skill, and commitment to helping patients explore practical options for healing and hope.
Medical Disclaimer
The information provided in this blog is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Treatment outcomes vary by individual. Ketamine therapy for depression is an off-label use and may not be appropriate for everyone. Consult with a qualified healthcare provider before beginning any new treatment, and discuss whether this treatment is appropriate for your medical history, psychiatric history, current medications, and treatment goals.